Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CDA”

193 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 193 results

Testing effectiveness (Phase 2)UnknownNCT01295593
What this trial is testing

Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 33
Not applicableStudy completedNCT04997148
What this trial is testing

Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 116
Testing effectiveness (Phase 2)UnknownNCT00126321
What this trial is testing

Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)

Who this might be right for
Leukemia, Myelocytic, Acute
University Hospital, Bonn 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02250937
What this trial is testing

Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT00003757
What this trial is testing

Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy

Who this might be right for
Leukemia
Swiss Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT00053027
What this trial is testing

Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 30
Not applicableEnded earlyNCT01289639
What this trial is testing

Insulin Resistance in Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
VA Office of Research and Development 11
Not applicableStudy completedNCT05275582
What this trial is testing

Developing a Team-Delivered Intervention for Smoking and Hazardous Drinking for Primary Care Veterans With Cardiovascular Diseases

Who this might be right for
Cigarette UseAlcohol Use Above Recommended LimitsCardiovascular Risk Factors (e.g., Hypertension)+1 more
VA Office of Research and Development 44
Testing effectiveness (Phase 2)Looking for participantsNCT02115295
What this trial is testing

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Myeloid LeukemiaBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+11 more
M.D. Anderson Cancer Center 508
Testing effectiveness (Phase 2)Looking for participantsNCT04797767
What this trial is testing

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Who this might be right for
Acute Biphenotypic LeukemiaAcute Myeloid LeukemiaMixed Phenotype Acute Leukemia+10 more
University of Washington 62
Post-approval studies (Phase 4)Active Not RecruitingNCT04178005
What this trial is testing

Cladribine Tablets After Treatment With Natalizumab (CLADRINA)

Who this might be right for
Multiple Sclerosis
University of Texas Southwestern Medical Center 40
Not applicableActive Not RecruitingNCT04239820
What this trial is testing

Effect of Cladribine Treatment on Microglial Activation in the CNS

Who this might be right for
Multiple Sclerosis
Turku University Hospital 15
Testing effectiveness (Phase 2)Ended earlyNCT01446900
What this trial is testing

R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukaemiaSmall Lymphocytic Lymphoma
European Institute of Oncology 25
Early research (Phase 1)Study completedNCT00258271
What this trial is testing

Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Rochester 18
Not applicableLooking for participantsNCT05683132
What this trial is testing

Treatments in Women Veterans With Insomnia and PTSD

Who this might be right for
InsomniaPTSDWomen Veterans
VA Office of Research and Development 100
Not applicableLooking for participantsNCT05666167
What this trial is testing

Expanding Exercise Programming for Veterans Through Telehealth

Who this might be right for
Arthritis
VA Office of Research and Development 50
Testing effectiveness (Phase 2)Study completedNCT02921061
What this trial is testing

Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS

Who this might be right for
Mixed Phenotype Acute LeukemiaPreviously Treated Myelodysplastic SyndromeRecurrent Adult Acute Myeloid Leukemia+4 more
Fred Hutchinson Cancer Center 28
Early research (Phase 1)UnknownNCT01439750
What this trial is testing

Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)

Who this might be right for
Mantle Cell Lymphoma
Milton S. Hershey Medical Center 13
Large-scale testing (Phase 3)Study completedNCT04121403
What this trial is testing

Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)

Who this might be right for
Relapsing Multiple SclerosisMultiple Sclerosis
Oslo University Hospital 267
Early research (Phase 1)Looking for participantsNCT06060782
What this trial is testing

Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine

Who this might be right for
Burkitt LymphomaLymphoblastic Lymphoma, AdultAcute Lymphoblastic Leukemia, Adult
Fifth Affiliated Hospital, Sun Yat-Sen University 28
Load More Results